These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 736994)
21. Modulation of cytotoxicity and metabolism of 5-fluorouracil in two intestine cell lines. Peters GJ; Laurensse E; Leyva A; Pinedo HM Adv Exp Med Biol; 1986; 195 Pt B():113-20. PubMed ID: 2429503 [No Abstract] [Full Text] [Related]
22. Effects of allopurinol on the therapeutic efficacy of methotrexate. Grindey GB; Moran RG Cancer Res; 1975 Jul; 35(7):1702-5. PubMed ID: 1131828 [TBL] [Abstract][Full Text] [Related]
23. Reversal of the in vitro methotrexate suppression of cell-mediated immune response by folinic acid and thymidine plus hypoxanthine. Bogyo D; Mihich E Cancer Res; 1980 Mar; 40(3):650-4. PubMed ID: 6970615 [TBL] [Abstract][Full Text] [Related]
24. [Establishment of a HAT selective medium-sensitive mutant human lymphoma cell line]. Ikewaki N; Yamaura N Nihon Saikingaku Zasshi; 1988 Mar; 43(2):577-81. PubMed ID: 3398235 [No Abstract] [Full Text] [Related]
25. Effect of 5-fluorouracil and thymidine on the transmembrane potential and zeta potential of HeLa cells. Walliser S; Redmann K Cancer Res; 1978 Oct; 38(10):3555-9. PubMed ID: 688241 [TBL] [Abstract][Full Text] [Related]
26. Effect of a transplantable leukemia on hematopoietic stem cells in AKR mice. Nakeff A; Valeriote FA Cancer Treat Rep; 1978 May; 62(5):737-41. PubMed ID: 657159 [TBL] [Abstract][Full Text] [Related]
27. Allopurinol modification of the toxicity and antitumor activity of 5-fluorouracil. Schwartz PM; Dunigan JM; Marsh JC; Handschumacher RE Cancer Res; 1980 Jun; 40(6):1885-9. PubMed ID: 7371020 [No Abstract] [Full Text] [Related]
28. Different effects of thymidine and 5-fluorouracil 2'-deoxyriboside on biosynthetic events in cultured P815Y mast cells. Bergeron JJ Biochem J; 1971 Jul; 123(3):385-90. PubMed ID: 4256660 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of growth of leukemia cells by enzymic folate depletion. Bertino JR; O'Brien P; McCullough JL Science; 1971 Apr; 172(3979):161-2. PubMed ID: 5313376 [TBL] [Abstract][Full Text] [Related]
30. Adaptation of a cholesterol deficient human T cell line to growth with lanosterol. Buttke TM; Van Cleave S Biochem Biophys Res Commun; 1994 Apr; 200(1):206-12. PubMed ID: 8166689 [TBL] [Abstract][Full Text] [Related]
31. Cytotoxic effect of a T-strain mycoplasma (Ureaplasma urealyticum) on cultured normal human cells (wi-38). Masover GK; Namba M; Hayflick L Exp Cell Res; 1976 May; 99(2):363-74. PubMed ID: 1269532 [No Abstract] [Full Text] [Related]
32. Modulation of antifolate cytotoxicity by metabolites from dying cells in a lymphocyte clonal assay. Hughes JM; deFazio A; Tattersall MH Br J Cancer; 1988 May; 57(5):459-63. PubMed ID: 3395552 [TBL] [Abstract][Full Text] [Related]
33. Effect of cis-located human satellite DNA on electroporation efficiency. Saint-Dic D; DuBow MS Methods Mol Biol; 1995; 48():199-210. PubMed ID: 8528392 [No Abstract] [Full Text] [Related]
34. Sequential combination of methotrexate and 1-beta-D-arabinofuranosylcytosine shows synergistic effect on the generation of DNA strand breaks in a human promyelocytic leukemia cell line. Tanizawa A; Kubota M; Takimoto T; Kito T; Akiyama Y; Kiriyama Y; Mikawa H Adv Exp Med Biol; 1989; 253B():349-54. PubMed ID: 2610122 [No Abstract] [Full Text] [Related]
35. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin. Mini E; Moroson BA; Bertino JR Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995 [TBL] [Abstract][Full Text] [Related]
36. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Copur S; Aiba K; Drake JC; Allegra CJ; Chu E Biochem Pharmacol; 1995 May; 49(10):1419-26. PubMed ID: 7763285 [TBL] [Abstract][Full Text] [Related]
37. Selective antagonism of 5-fluorouracil cytotoxicity by 4-hydroxypyrazolopyrimidine (allopurinol) in vitro. Schwartz PM; Handschumacher RE Cancer Res; 1979 Aug; 39(8):3095-101. PubMed ID: 455294 [No Abstract] [Full Text] [Related]
38. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies. Jackman AL; Alison DL; Calvert AH; Harrap KR Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731 [TBL] [Abstract][Full Text] [Related]
39. Regulation of the activity of heme degradative enzymes in K562 erythroleukemic cells: induction by thymidine. Trakshel GM; Rowley PT; Maines MD Exp Hematol; 1987 Sep; 15(8):859-63. PubMed ID: 3113993 [TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells. Smith SG; Lehman NL; Moran RG Cancer Res; 1993 Dec; 53(23):5697-706. PubMed ID: 8242626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]